Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Strait of Hormuz at Center of Crisis as Iran Rejects Ceasefire Proposal

Iran Rejects Temporary Ceasefire as Deadline Nears, Intensifying…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Rapture, Tribulation, and Truth: Clearing the Confusion in Revelation 3:10

Questions About Allegiance, Prophecy and Salvation in the End…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Middle East Power Shift: Trump Claims Victory Over Iran as Prophecy Watch Intensifies

Trump Says Iran Is “No Longer a Threat,” but Christians Should…
Read more